Aytu Biopharma (AYTU) Work In Process (2021 - 2026)

Aytu Biopharma (AYTU) has 6 years of Work In Process data on file, last reported at $2.0 million in Q1 2026.

• On a quarterly basis, Work In Process fell 0.63% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 0.63% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 75.88% from the prior year.
• Work In Process for Q1 2026 stood at $2.0 million, up from $1.8 million in the prior quarter.
• Over the last five years, Work In Process for AYTU reached as high as $5.7 million in Q2 2024 and fell as low as $862000.0 in Q3 2025.
• Historically, Work In Process has averaged $2.7 million across 5 years, with a median of $2.7 million in 2023.
• Across the five-year window, Work In Process jumped 93.67% in 2024 and slumped 75.88% in 2025, its largest moves.
• Year by year, Work In Process stood at $2.8 million in 2022, then declined by 4.6% to $2.7 million in 2023, then climbed by 16.04% to $3.1 million in 2024, then plunged by 41.48% to $1.8 million in 2025, then increased by 12.72% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $2.0 million in Q1 2026, $1.8 million in Q4 2025, and $862000.0 in Q3 2025.